Pfizer Beats Q4 2025 Estimates as Non-COVID Growth Fuels Momentum
Pfizer beats Q4 2025 estimates on non-COVID growth and outlines a steady 2026 outlook across vaccines, oncology, and more.
Pfizer beats Q4 2025 estimates on non-COVID growth and outlines a steady 2026 outlook across vaccines, oncology, and more.
Delta Air Lines, one of the world's largest airlines, recently announced a cut to their 2025 profit outlook due to tariffs and hesitant consumers. However, the CEO remains optimistic about stabilized demand.
United Airlines lifts its Q4 earnings outlook, citing revenue gains and cost efficiency fueling investor confidence.
Constellation Brands reaffirms lowered full-year guidance amid macro headwinds while focusing on beer, wine, and spirits.
Despite challenges, Home Depot remains optimistic about the future and its ability to adapt and overcome.